학술논문
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
Document Type
Article
Author
Source
In European Journal of Cancer October 2023 192
Subject
Language
ISSN
0959-8049